Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

NCT00329693 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG: Norprolac
DRUG: Norprolac
DRUG: Norprolac
DRUG: Norprolac

Sponsor

Ferring Pharmaceuticals